Literature DB >> 6872464

Splenic function in sickle-cell diseases.

M A Zago, C Bottura.   

Abstract

Studies of splenic function were carried out on patients with sickle-cell diseases by the measurement of the clearance of autologous heat-damaged 99mTc-labelled erythrocytes from circulation and into the spleen, the spleen area by a scintillation scanning, the enumeration of pitted erythrocytes by direct-interference microscopy, and the percentage of irreversibly sickled cells (ISC) and of cells with Howell-Jolly bodies. All measurements were performed in seven HbS homozygotes, 10 patients with sickle cell beta(0)-thalassaemia (S/beta(0)-thalassaemia), three patients with sickle-cell disease (SC), four AS heterozygotes and 17 controls. Three different patterns of splenic function were observed among the 20 patients with symptomatic sickle-cell diseases: six patients had enlarged hyperactive spleens, four had enlarged hypoactive spleens, and in 10 patients no splenic activity was detected. The percentage of ISC was higher in sickle-cell anaemia than in S/beta (0)-thalassaemia and very low in SC patients. These results would suggest that the spleen goes through similar successive functional stages in the sickle-cell diseases, namely enlargement in the early years of life, which is followed by hypoactivity and finally atrophy. This evolution seems to be faster in sickle-cell anaemia than in S/beta(0)-thalassaemia and SC disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872464     DOI: 10.1042/cs0650297

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Circulating immune complexes after splenectomy.

Authors:  E A Donadi; I F Carvalho; R P Falcão
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

2.  Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial.

Authors:  Russell E Ware; Renee C Rees; Sharada A Sarnaik; Rathi V Iyer; Ofelia A Alvarez; James F Casella; Barry L Shulkin; Eglal Shalaby-Rana; C Frederic Strife; John H Miller; Peter A Lane; Winfred C Wang; Scott T Miller
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

Review 3.  Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

4.  Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy.

Authors:  E A Donadi; R P Falcão
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

5.  Pitted red cell counts in Nigerian children with sickle cell anemia: correlation with age and splenic size.

Authors:  A D Adekile; C A Reindorf; O A Adeodu; W Johnson; B A Dairo
Journal:  J Natl Med Assoc       Date:  1991-04       Impact factor: 1.798

6.  Aspects of splenic hypofunction in old age.

Authors:  M A Zago; M S Figueiredo; D T Covas; C Bottura
Journal:  Klin Wochenschr       Date:  1985-07-01

Review 7.  Assessment of splenic function.

Authors:  A P N A de Porto; A J J Lammers; R J Bennink; I J M ten Berge; P Speelman; J B L Hoekstra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-19       Impact factor: 3.267

8.  HAEMATOLOGICAL PROFILE AND BLOOD TRANSFUSION PATTERN OF PATIENTS WITH SICKLE CELL ANAEMIA VARY WITH SPLEEN SIZE.

Authors:  F A Fasola; A J Adekanmi
Journal:  Ann Ib Postgrad Med       Date:  2019-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.